JP2711828B2 - Method for producing (6R) -tetrahydro-L-biopterin hydrochloride - Google Patents

Method for producing (6R) -tetrahydro-L-biopterin hydrochloride

Info

Publication number
JP2711828B2
JP2711828B2 JP8164213A JP16421396A JP2711828B2 JP 2711828 B2 JP2711828 B2 JP 2711828B2 JP 8164213 A JP8164213 A JP 8164213A JP 16421396 A JP16421396 A JP 16421396A JP 2711828 B2 JP2711828 B2 JP 2711828B2
Authority
JP
Japan
Prior art keywords
biopterin
hydrochloride
tetrahydro
producing
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP8164213A
Other languages
Japanese (ja)
Other versions
JPH09157270A (en
Inventor
秀昭 酒井
貞 金井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiratori Pharmaceutical Co Ltd
Suntory Ltd
Original Assignee
Shiratori Pharmaceutical Co Ltd
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiratori Pharmaceutical Co Ltd, Suntory Ltd filed Critical Shiratori Pharmaceutical Co Ltd
Priority to JP8164213A priority Critical patent/JP2711828B2/en
Publication of JPH09157270A publication Critical patent/JPH09157270A/en
Application granted granted Critical
Publication of JP2711828B2 publication Critical patent/JP2711828B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Description

【発明の詳細な説明】 【0001】 【発明の属する技術分野】本発明は次式(1) 【0002】 【化1】 【0003】で表わされる(6R)−テトラヒドロ−L
−バイオプテリンの製造法、更に詳細には、テトラヒド
ロ−L−バイオプテリンの6R体を高い比率で得ること
ができる工業的な製造法に関する。 【0004】 【従来の技術及び発明が解決しようとする課題】テトラ
ヒドロ−L−バイオプテリン(以下「BPH4」と略称
する)には6位の水素の立体配置により6R体と6S体
の異性体が存在する〔Furrer,H.J. ら:Helv.Chim.Act
a,62,2577(1979)〕。そして、就中(6R)−BPH4
フェニルアラニン水酸化酵素の補酵素であると同時に、
他の芳香族アミノ酸水酸化酵素の補酵素でもある。それ
ゆえ、その欠乏は神経伝達物質であるセロトニン、ドー
パミン、ノルアドレナリン、アドレナリンなどを欠乏さ
せ、重篤な神経症状をおこさせる。また、先天性代謝異
常症の一つである悪性高フェニルアラニン血症は既存の
薬物療法では容易には治療できない難病であるが、これ
は(6R)−BPH4の欠乏によりフェニルアラニンの
チロシンへの変換が阻害されるために起ることが知られ
ている。 【0005】悪性高フェニルアラニン血症の治療に(6
R)−BPH4の投与が考えられるが、そのためには本
品を高純度に経済的に製造する方法の開発が望まれてい
る。 【0006】テトラヒドロ−L−バイオプテリンを製造
する方法としては、L−エリスロ−バイオプテリンを酵
素的あるいは化学的に還元する方法が知られている。就
中酵素法は6R体のみが得られるという利点はあるが、
装置及び操作が繁雑であると共に製造コストが高く工業
的方法としては不利なるを免れない。一方化学的方法に
よると、6R体と6S体の混合物を生じ、これは分割し
なければならないが、この分割は極めて困難であり、現
在その有利な分割法は知られていない。 【0007】従って、従来から(6R)−BPHを高
比率で、出来得ればこれを選択的に合成し、単離収得す
る方法の開発が望まれているが、未だ満足な方法は見出
されていない。 【0008】 【課題を解決するための手段】斯かる実情において、本
発明者は鋭意研究を行った結果、L−エリスロ−バイオ
プテリン又はそのアシル誘導体を白金黒を触媒として特
定の条件下接触還元すれば、不斉合成率R/Sを著しく
高めることができ、しかもこのような高いR/S値のも
のであれば塩酸塩として容易に高純度の(6R)−BP
を高収率にて分離収得できることを見出し、本発明
を完成した。 【0009】従って、本発明は、L−エリスロ−バイオ
プテリン又はそのアシル誘導体(2)を白金黒を触媒と
してアミン類の存在下pH10〜13で接触還元し、ア
シル基が存在する場合にはこれを脱離し、次いでこれを
塩酸塩として単離収得することからなる(6R)−テト
ラヒドロ−L−バイオプテリン(1)の塩酸塩を製造す
る方法であり、この接触還元反応は次の反応式によって
示される。 【0010】 【化2】 【0011】(式中、RはH又はアシル基を示す) 【0012】 【発明の実施の形態】本発明を実施するには、L−エリ
スロ−バイオプテリン又はそのアシル誘導体(2)をア
ミン類でpH10〜13に調整した水、アルコール系又は
これらの混合溶媒中で白金黒を触媒として接触還元す
る。 【0013】アルコール系溶媒としては、メタノール、
エタノール、メチルセルソルブ、エチレングリコール等
が挙げられる。アミン類としては、メチルアミン、エチ
ルアミン、シクロヘキシルアミン等の第1級アミン、ジ
メチルアミン、ジエチルアミン、ピペリジン、モルホリ
ン等の第2級アミン、トリメチルアミン、トリエチルア
ミン等の第3級アミン、テトラメチルアンモニウムヒド
ロキシド、テトラエチルアンモニウムヒドロキシド、ベ
ンジルトリメチルアンモニウムヒドロキシド等の第4級
アミン等が挙げられる。このアミン類はpH10〜13に
なるように添加すればよく、pHがこれより低くなると、
不斉合成率が低下し、高くなると不斉合成率R/S及び
収率が共に低下する。 【0014】触媒は種々の触媒、就中白金系触媒の中で
も白金黒が特異的であり、他のものに比較し極めて高い
不斉合成率R/Sを示す。 【0015】本発明方法は通常の接触還元の操作によっ
て行うことができ、反応温度は−10℃〜50℃が、H
2圧力は1kg/cm2 以上、特に1〜100kg/cm2 が好
ましい。 【0016】このようにするとき、不斉合成率R/S約
7以上にて(6R)−BPH又はそのアシル誘導体を
得ることができる。アシル基の一部は上記反応によって
除去されるが、まだこれが残存する場合には、塩酸等に
よって加水分解することにより容易に除去される。この
生成物を再結晶することにより高純度の(6R)−BP
の塩酸塩を単離収得することができる。 【0017】 【発明の効果】叙上の如く、本発明は、従来化学的合成
法では製造困難であった(6R)−BPHを高い不斉
合成率R/Sで合成し、しかもその6R体を塩酸塩とし
て容易に高純度、高収率にて単離収得することに成功し
た極めて優れた工業的製法である。 【0018】 【実施例】次に実施例を挙げて説明する。 【0019】実施例1 L−エリスロ−バイオプテリン1.0g(4.22ミリ
モル)、白金ブラック0.20gを水95mlに加え、こ
れに10%テトラエチルアンモニウムヒドロキシドを加
え、pH=12.0に調整した。これをオートクレーブに
入れ、H2圧力100kg/cm2 、温度0〜5℃、回転数
1000r.p.m.で攪拌し20時間反応させた。反応物に
濃塩酸5mlを加え、触媒を濾過して除き、減圧下浴温3
5℃以下で濃縮し、残留物を3N塩酸とエタノールの混
合溶媒より再結晶した。 【0020】融点244.5℃(分解)の白色結晶、
(6R)−BPH42HClを1.13g得た。 【0021】 元素分析値 理論値(%) 分析値(%) C917Cl253 C 34.41 34.50 H 5.45 5.41 N 22.29 22.58 旋光度〔α〕D 25:−6.39°(C,0.68;0.
1N HCl)1 H−NMR(CD3OD−D2O):4.10−3.7
0(5H,m,H−C(6,7,1′,2′)),1.
40(3H,d,J=6Hz,H−C(3′)) 【0022】実施例2 L−エリスロ−バイオプテリン1.0g(4.22ミリ
モル)、白金ブラック0.20gを水95mlに加え、こ
れに表1の塩基を加え所定pHに調整した。これをオート
クレーブに入れ、H2圧力100kg/cm2 、温度0〜5
℃、回転数1000r.p.m.で攪拌し20時間反応させ
た。反応物に濃塩酸5mlを加え、触媒を濾過して除き、
この濾液部について高速液体クロマトグラフィーで分析
し、それぞれのR/S比及び(R体+S体)の収率をも
とめた。その結果は表1の通りである。 【0023】高速液体クロマトグラフィー測定条件 検出器:紫外吸光光度計(測定波長:275nm) カラム:Partisil-10SCX,4.5×250 mm 移動相:30mMリン酸アンモニウム・3mM亜硫酸アンモニ
ウム(pH=3.0) 流 量:2ml/min 【0024】 【表1】 【0025】実施例3 塩基として、トリエチルアミン、ジエチルアミン、エチ
ルアミン及びテトラエチルアンモニウムヒドロキシドを
使用してpHを12に調整し、反応温度とH2圧力を変え
て実施例2と同様に操作した。その結果は表2〜表5の
とおりである。 【0026】 【表2】【0027】 【表3】 【0028】 【表4】 【0029】 【表5】 【0030】実施例4 L−エリスロ−バイオプテリン20mg、白金黒4mgを表
6の溶媒2mlに加え、表6の塩基を加えて所定pHに調整
した。これをオートクレーブに入れ、H2圧力100kg
/cm2 、表6の温度で20時間反応させた。反応物を実
施例2と同様に操作して、不斉合成率R/Sと(R体+
S体)収率を測定した。その結果は表6のとおりであ
る。 【0031】 【表6】 【0032】実施例5 水又は有機溶媒2mlにトリアセチル−L−エリスロ−
バイオプテリン20mg、白金黒4mg及び表7の塩基
を加え、所定pHに調整し、オートクレーブ中で、H
気圧100kg/cm、温度20℃にて20時間反応
させた。反応物に3N塩酸2mlを加え、触媒を濾去
し、濾液1.5mlに濃塩酸0.5mlを加え、3日間
放置して脱アセチル化した。これを実施例2と同条件下
高速液体クロマトグラフィーで分析し、R/Sと(R体
+S体)収率を測定した。その結果は表7のとおりであ
る。 【0033】 【表7】
Description: BACKGROUND OF THE INVENTION [0001] The present invention relates to the following formula (1): (6R) -tetrahydro-L represented by
The present invention relates to a method for producing biopterin, and more particularly to an industrial method for producing a 6R-form of tetrahydro-L-biopterin at a high ratio. [0004] Tetrahydro-L-biopterin (hereinafter abbreviated as "BPH 4 ") has 6R- and 6S-isomers due to the configuration of hydrogen at the 6-position. [Furrer, HJ et al .: Helv. Chim. Act
a, 62, 2577 (1979)]. And (6R) -BPH 4 is a coenzyme for phenylalanine hydroxylase,
It is also a coenzyme for other aromatic amino acid hydroxylases. Therefore, the deficiency causes the deficiency of neurotransmitters such as serotonin, dopamine, noradrenaline, and adrenaline, causing severe neurological symptoms. Although malignant hyperphenylalaninemia, one of congenital metabolic disorders are intractable diseases that can not be treated as easily with existing drug therapy, which is converted to phenylalanine tyrosine by a deficiency of (6R) -BPH 4 Is known to be caused by inhibition. For the treatment of malignant hyperphenylalaninemia (6)
Although the administration of R) -BPH 4 is considered, the development of a method to economically produce this product in high purity is desired for that. [0006] As a method for producing tetrahydro-L-biopterin, a method for enzymatically or chemically reducing L-erythro-biopterin is known. Although the enzymatic method has the advantage that only the 6R form can be obtained,
The equipment and operation are complicated, the production cost is high, and the method is inevitably disadvantageous as an industrial method. On the other hand, the chemical method produces a mixture of the 6R and 6S forms, which must be resolved, but this resolution is very difficult and no advantageous method is currently known. Accordingly, conventionally the (6R) -BPH 4 a high proportion, if Ere can selectively synthesize this, although the development of a method for Shutoku isolation is desired, seen yet satisfactory way Not issued. Under such circumstances, the present inventors have conducted intensive studies and as a result, have found that L-erythro-biopterin or its acyl derivative can be catalytically reduced under a specific condition using platinum black as a catalyst. By doing so, the asymmetric synthesis rate R / S can be remarkably increased, and if the R / S value is high, (6R) -BP having a high purity can be easily obtained as a hydrochloride.
The H 4 found to be able to separate Shutoku at high yield, thereby completing the present invention. Accordingly, the present invention provides a method for catalytically reducing L-erythro-biopterin or its acyl derivative (2) at a pH of 10 to 13 in the presence of amines using platinum black as a catalyst. And then isolating and obtaining the hydrochloride as a hydrochloride, thereby producing a hydrochloride of (6R) -tetrahydro-L-biopterin (1). The catalytic reduction reaction is carried out according to the following reaction formula. Is shown. [0010] (In the formula, R represents H or an acyl group) DETAILED DESCRIPTION OF THE INVENTION In order to carry out the present invention, L-erythro-biopterin or an acyl derivative (2) thereof is substituted with an amine. In water, alcohol or a mixed solvent thereof adjusted to pH 10 to 13 with platinum black as a catalyst. As the alcohol solvent, methanol,
Ethanol, methyl cellosolve, ethylene glycol and the like can be mentioned. Examples of the amines include primary amines such as methylamine, ethylamine and cyclohexylamine; secondary amines such as dimethylamine, diethylamine, piperidine and morpholine; tertiary amines such as trimethylamine and triethylamine; tetramethylammonium hydroxide; And quaternary amines such as tetraethylammonium hydroxide and benzyltrimethylammonium hydroxide. The amines may be added so as to have a pH of 10 to 13. When the pH is lower than this,
The asymmetric synthesis rate decreases, and as the rate increases, both the asymmetric synthesis rate R / S and the yield decrease. As the catalyst, platinum black is specific among various catalysts, especially platinum-based catalysts, and exhibits an extremely high asymmetric synthesis rate R / S as compared with other catalysts. The process of the present invention can be carried out by a usual operation of catalytic reduction, and the reaction temperature is from -10 ° C to 50 ° C.
2 pressure 1 kg / cm 2 or more, especially 1 to 100 kg / cm 2 is preferred. [0016] When such may be obtained by asymmetric synthesis rate R / S to about 7 or more (6R) -BPH 4 or acyl derivatives thereof. A part of the acyl group is removed by the above reaction, but if it still remains, it is easily removed by hydrolysis with hydrochloric acid or the like. By recrystallizing this product, high-purity (6R) -BP
The hydrochloride salt of H 4 can be Shutoku isolated. [0017] As the ordination according to the present invention, the present invention is, in the conventional chemical synthesis and synthesis was difficult to produce the (6R) -BPH 4 with high asymmetric synthesis rate R / S, yet its 6R This is an extremely excellent industrial production method which succeeded in isolating and obtaining the compound as a hydrochloride easily and with high purity and high yield. Next, an embodiment will be described. Example 1 1.0 g (4.22 mmol) of L-erythro-biopterin and 0.20 g of platinum black were added to 95 ml of water, and 10% tetraethylammonium hydroxide was added thereto to adjust the pH to 12.0. It was adjusted. This was placed in an autoclave, stirred at an H 2 pressure of 100 kg / cm 2 , a temperature of 0 to 5 ° C., and a rotation speed of 1000 rpm to react for 20 hours. 5 ml of concentrated hydrochloric acid was added to the reaction product, and the catalyst was removed by filtration.
After concentrating at 5 ° C. or lower, the residue was recrystallized from a mixed solvent of 3N hydrochloric acid and ethanol. White crystals having a melting point of 244.5 ° C. (decomposition)
1.13 g of (6R) -BPH 4 2HCl was obtained. Elemental analysis value Theoretical value (%) Analysis value (%) C 9 H 17 Cl 2 N 5 O 3 C 34.41 34.50 H 5.45 5.41 N 22.29 22.58 Optical rotation [ α] D 25 : −6.39 ° (C, 0.68;
1N HCl) 1 H-NMR ( CD 3 OD-D 2 O): 4.10-3.7
0 (5H, m, H-C (6,7,1 ', 2')), 1.
40 (3H, d, J = 6 Hz, HC (3 ')) Example 2 1.0 g (4.22 mmol) of L-erythro-biopterin and 0.20 g of platinum black were added to 95 ml of water. Then, the base shown in Table 1 was added thereto to adjust the pH to a predetermined value. This was put in an autoclave, and the H 2 pressure was 100 kg / cm 2 , and the temperature was 0-5.
The mixture was stirred for 20 hours at a temperature of 1000 ° C. and a rotation speed of 1000 rpm. 5 ml of concentrated hydrochloric acid was added to the reaction product, and the catalyst was removed by filtration.
The filtrate was analyzed by high performance liquid chromatography, and the R / S ratio and the yield of (R-form + S-form) were determined. Table 1 shows the results. High-performance liquid chromatography measurement conditions Detector: UV absorption spectrophotometer (measurement wavelength: 275 nm) Column: Partisil-10SCX, 4.5 × 250 mm Mobile phase: 30 mM ammonium phosphate / 3 mM ammonium sulfite (pH = 3.0) Flow rate: 2 ml / min [Table 1] Example 3 The same operation as in Example 2 was carried out by adjusting the pH to 12 using triethylamine, diethylamine, ethylamine and tetraethylammonium hydroxide as bases, and changing the reaction temperature and H 2 pressure. The results are as shown in Tables 2 to 5. [Table 2] [Table 3] [Table 4] [Table 5] Example 4 20 mg of L-erythro-biopterin and 4 mg of platinum black were added to 2 ml of the solvent shown in Table 6, and the pH was adjusted to a predetermined value by adding a base shown in Table 6. Put this in an autoclave, H 2 pressure 100kg
/ Cm 2, and allowed to react for 20 hours at a temperature shown in Table 6. The reaction product was operated in the same manner as in Example 2, and the asymmetric synthesis rate R / S and (R-form +
(S-isomer) The yield was measured. Table 6 shows the results. [Table 6] Example 5 Triacetyl-L-erythro- was added to 2 ml of water or an organic solvent.
Bio pterin 20 mg, a base platinum black 4mg and Table 7 was added, it was adjusted to a predetermined pH, in an autoclave, H 2
The reaction was carried out at a pressure of 100 kg / cm 2 and a temperature of 20 ° C. for 20 hours. 2 ml of 3N hydrochloric acid was added to the reaction product, the catalyst was removed by filtration, 0.5 ml of concentrated hydrochloric acid was added to 1.5 ml of the filtrate, and the mixture was left for 3 days to deacetylate. This was analyzed by high performance liquid chromatography under the same conditions as in Example 2 to determine the R / S and the (R-form + S-form) yield. Table 7 shows the results. [Table 7]

Claims (1)

(57)【特許請求の範囲】 1.L−エリスロ−バイオプテリン又はそのアシル誘導
体を白金黒を触媒としてアミン類の存在下pH10〜13
で接触還元し、アシル基が存在する場合にはこれを脱離
し、次いでこれを(6R)−テトラヒドロ−L−バイオ
プテリン塩酸塩として単離収得することを特徴とする
(6R)−テトラヒドロ−L−バイオプテリン塩酸塩の
製造法。 2.H2圧力20kg/cm2 以上で接触還元を行うことを
特徴とする請求項1記載の製造法。 3.20℃以下の温度で接触還元を行うことを特徴とす
る請求項1又は2記載の製造法。 4.反応を水又は/及びアルコール系溶媒中行うことを
特徴とする請求項1〜3のいずれか1項記載の製造法。
(57) [Claims] L-erythro-biopterin or an acyl derivative thereof was prepared by using platinum black as a catalyst in the presence of amines at pH 10-13.
(6R) -tetrahydro-L is isolated and obtained as (6R) -tetrahydro-L-biopterin hydrochloride. -A process for producing biopterin hydrochloride. 2. 2. The method according to claim 1, wherein the catalytic reduction is carried out at an H 2 pressure of 20 kg / cm 2 or more. 3. The process according to claim 1, wherein the catalytic reduction is carried out at a temperature of 20 ° C. or lower. 4. The method according to any one of claims 1 to 3, wherein the reaction is performed in water or / and an alcohol solvent.
JP8164213A 1996-06-25 1996-06-25 Method for producing (6R) -tetrahydro-L-biopterin hydrochloride Expired - Lifetime JP2711828B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8164213A JP2711828B2 (en) 1996-06-25 1996-06-25 Method for producing (6R) -tetrahydro-L-biopterin hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8164213A JP2711828B2 (en) 1996-06-25 1996-06-25 Method for producing (6R) -tetrahydro-L-biopterin hydrochloride

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP60012477A Division JPS61172876A (en) 1985-01-28 1985-01-28 Production of (6r)-tetrahydro-l-biopterin

Publications (2)

Publication Number Publication Date
JPH09157270A JPH09157270A (en) 1997-06-17
JP2711828B2 true JP2711828B2 (en) 1998-02-10

Family

ID=15788823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8164213A Expired - Lifetime JP2711828B2 (en) 1996-06-25 1996-06-25 Method for producing (6R) -tetrahydro-L-biopterin hydrochloride

Country Status (1)

Country Link
JP (1) JP2711828B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178670B2 (en) 2008-01-07 2012-05-15 Biomarin Pharmaceutical Inc. Method of synthesizing tetrahydrobiopterin

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3138566T3 (en) 2003-11-17 2022-03-07 Biomarin Pharmaceutical Inc. Treatment of phenylketonuria with bh4
AU2005306686B2 (en) 2004-11-17 2011-06-02 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
ES2317529T3 (en) 2005-04-14 2009-04-16 Shiratori Pharmaceutical Co., Ltd. METHOD FOR PRODUCING CRYSTALS OF ALFA HYDROCLORIDE FORM OF SAPROPTERINA.
ES2906582T3 (en) 2007-04-11 2022-04-19 Biomarin Pharm Inc Methods for administering tetrahydrobiopterin, associated compositions and measurement methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN,VOL.46,NO.1,PP.279−282(1973)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178670B2 (en) 2008-01-07 2012-05-15 Biomarin Pharmaceutical Inc. Method of synthesizing tetrahydrobiopterin

Also Published As

Publication number Publication date
JPH09157270A (en) 1997-06-17

Similar Documents

Publication Publication Date Title
US4713454A (en) Preparation process of (6R)-tetrahydro-L-biopterin
US5037981A (en) Intermediates for synthesizing BH4 and its derivatives
JPH11505229A (en) Method for producing 4-aryl-piperidine derivatives
US4649197A (en) Sulfate of 5,6,7,8-tetrahydro-L-erythro-biopterin and process for preparing the same
US20230054325A1 (en) Compositions comprising folic acid derivatives, their preparations and methods of use
JP2711828B2 (en) Method for producing (6R) -tetrahydro-L-biopterin hydrochloride
JP3166125B2 (en) Production method of indole derivatives
JPH0586393B2 (en)
JPH0413357B2 (en)
RU2109013C1 (en) Method for stereoselective synthesis of alkylated hydroxyindoles and method for preparing optically pure alkylated hydroxyindole enantiomer
CA1231719A (en) Synthesis of phenyl alanine derivatives
JPH04342566A (en) Method for enantio-selectively synthesizing alkylated hydroxyindole used as intermediate in manufacture of physostigmine
US5099067A (en) Use of ammonium formate as a hydrogen transfer reagent for reduction of chiral nitro compounds with retention of configuration
JP2995448B2 (en) Method for producing (6S) -tetrahydro-D-neopterin
HU191160B (en) Process for regeneration of 6-fluor-4-cromanon from secondary products of sorbonile synthesis
JP2674707B2 (en) L-Biopterin manufacturing method
SU1240354A3 (en) Method of producing pyrbuterol dihydrochloride
US20060009652A1 (en) N-(4-oxo-butanoic acid) -L-amino acid-ester derivatives and methods of preparation thereof
EP1142864A1 (en) Process for producing l-erythro-(1r,2s)-2-amino-1-phenylpropan-1-ol
CN115521317A (en) Method for preparing nafrafine intermediate
CN116178252A (en) Raw material impurity of dabigatran etexilate mesylate, and preparation method and application thereof
JP2000212143A (en) Production and purification of optically active amidocarboxylic acid
JPS6379879A (en) Production of hydantoins
JPH01143871A (en) Dihydropteridine derivative
JPH05331106A (en) Production of phenylacetic acid derivative

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term